Exhibit 23.2


               Consent of Ernst & Young LLP, Independent Auditors

We consent to the  incorporation  by  reference in the  Registration  Statements
(Form  S-8  Nos.  333-06065,  333-32301,  333-60343,  333-42840  and  333-91588)
pertaining to the 1992 Stock Option Plan,  the 1995 Equity  Incentive  Plan, and
the 1995 Directors' Stock Option Plan, and the Registration Statements (Form S-3
Nos.  333-11457,  333-36057,  333-46087,  333-86193,  333-49466,  333-64864  and
333-102485) of Cellegy Pharmaceuticals, Inc. and in the related Prospectuses, of
our report dated  February 13, 2003 (except for Note 13, as to which the date is
March 24, 2004), with respect to the 2002 consolidated  financial  statements of
Cellegy Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the
year ended December 31, 2003.

                                               /s/ ERNST & YOUNG LLP


Palo Alto, California
April 6, 2004